← Open Payments lookup

HONG CAI: Open Payments

NPI 1851056303 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$772 in 29 payments from 20 companies in 2025. Trend: 2023 $679 · 2024 $705 · 2025 $772

Food & beverage: $772
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.4$172
Janssen Biotech, Inc.2$63
TAIHO ONCOLOGY, INC.3$62
Merck Sharp & Dohme LLC2$57
GlaxoSmithKline, LLC.2$53
Iovance Biotherapeutics, Inc.1$47
Incyte Corporation2$43
Takeda Pharmaceuticals U.S.A., Inc.1$33
AstraZeneca Pharmaceuticals LP1$31
Rigel Pharmaceuticals, Inc.1$24

Products named: LIBTAYO, LONSURF, KEYTRUDA, Amtagvi, JAKAFI, RYBREVANT, FRUZAQLA, JEMPERLI.

Industry payments across WA — which companies pay providers there.